These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3057331)

  • 21. Heterogeneity of lipid A: comparison of lipid A types from different gram-negative bacteria.
    Mattsby-Baltzer I; Gemski P; Alving CR
    J Bacteriol; 1984 Sep; 159(3):900-4. PubMed ID: 6384185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of lipid A: structural determination by 13C and 31P NMR of lipid A fractions from lipopolysaccharide of Escherichia coli 0111.
    Baltzer LH; Mattsby-Baltzer I
    Biochemistry; 1986 Jun; 25(12):3570-5. PubMed ID: 3521727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.
    Baker PJ; Hraba T; Taylor CE; Stashak PW; Fauntleroy MB; Zähringer U; Takayama K; Sievert TR; Hronowski X; Cotter RJ
    Infect Immun; 1994 Jun; 62(6):2257-69. PubMed ID: 8188347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
    Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
    Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical structure and biologic activity of bacterial and synthetic lipid A.
    Rietschel ET; Brade L; Brandenburg K; Flad HD; de Jong-Leuveninck J; Kawahara K; Lindner B; Loppnow H; Lüderitz T; Schade U
    Rev Infect Dis; 1987; 9 Suppl 5():S527-36. PubMed ID: 3317748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D-glucosamine subunit of lipid A.
    Kumazawa Y; Matsuura M; Maruyama T; Homma JY; Kiso M; Hasegawa A
    Eur J Immunol; 1986 Sep; 16(9):1099-103. PubMed ID: 3489621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual lipid A types in phototrophic bacteria and related species.
    Mayer H; Salimath PV; Holst O; Weckesser J
    Rev Infect Dis; 1984; 6(4):542-5. PubMed ID: 6474014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative X-ray and Fourier-transform-infrared investigations of conformational properties of bacterial and synthetic lipid A of Escherichia coli and Salmonella minnesota as well as partial structures and analogues thereof.
    Labischinski H; Naumann D; Schultz C; Kusumoto S; Shiba T; Rietschel ET; Giesbrecht P
    Eur J Biochem; 1989 Feb; 179(3):659-65. PubMed ID: 2646121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues.
    Homma JY; Matsuura M; Kanegasaki S; Kawakubo Y; Kojima Y; Shibukawa N; Kumazawa Y; Yamamoto A; Tanamoto K; Yasuda T
    J Biochem; 1985 Aug; 98(2):395-406. PubMed ID: 4066647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of 9-hydroxy-delta-tetradecalactone from lipid A of Pseudomonas diminuta and Pseudomonas vesicularis.
    Arata S; Hirayama T; Kasai N; Itoh T; Ohsawa A
    FEMS Microbiol Lett; 1989 Jul; 51(1):219-22. PubMed ID: 2777066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the chemical structure and biological activities of the glycolipids of Salmonella minnesota R595 and Salmonella typhimurium SL1102.
    Ng AK; Chang CM; Chen CH; Nowotny A
    Infect Immun; 1974 Oct; 10(4):938-47. PubMed ID: 4139122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endotoxic glycolipid from a heptoseless mutant of Salmonella minnesota.
    Kasai N; Nowotny A
    J Bacteriol; 1967 Dec; 94(6):1824-36. PubMed ID: 4965363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural analysis of the lipid A component of Campylobacter jejuni CCUG 10936 (serotype O:2) lipopolysaccharide. Description of a lipid A containing a hybrid backbone of 2-amino-2-deoxy-D-glucose and 2,3-diamino-2,3-dideoxy-D-glucose.
    Moran AP; Zähringer U; Seydel U; Scholz D; Stütz P; Rietschel ET
    Eur J Biochem; 1991 Jun; 198(2):459-69. PubMed ID: 2040305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme.
    Munford RS; Hall CL
    Science; 1986 Oct; 234(4773):203-5. PubMed ID: 3529396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid A fractions analyzed by a technique involving thin-layer chromatography and enzyme-linked immunosorbent assay.
    Mattsby-Baltzer I; Alving CR
    Eur J Biochem; 1984 Jan; 138(2):333-7. PubMed ID: 6365543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of human interleukin 1 by bacterial and synthetic lipid A.
    Loppnow H; Brade L; Brade H; Rietschel ET; Kusumoto S; Shiba T; Flad HD
    Eur J Immunol; 1986 Oct; 16(10):1263-7. PubMed ID: 3490388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A.
    Galanos C; Lehmann V; Lüderitz O; Rietschel ET; Westphal O; Brade H; Brade L; Freudenberg MA; Hansen-Hagge T; Lüderitz T
    Eur J Biochem; 1984 Apr; 140(2):221-7. PubMed ID: 6714230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural requirements of lipid A species in activation of clotting enzymes from the horseshoe crab, and the human complement cascade.
    Takada H; Kotani S; Tanaka S; Ogawa T; Takahashi I; Tsujimoto M; Komuro T; Shiba T; Kusumoto S; Kusunose N
    Eur J Biochem; 1988 Aug; 175(3):573-80. PubMed ID: 3044789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural characterization of the lipid A component of Pseudomonas aeruginosa wild-type and rough mutant lipopolysaccharides.
    Kulshin VA; Zähringer U; Lindner B; Jäger KE; Dmitriev BA; Rietschel ET
    Eur J Biochem; 1991 Jun; 198(3):697-704. PubMed ID: 1904818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506).
    Ogawa T; Suda Y; Kashihara W; Hayashi T; Shimoyama T; Kusumoto S; Tamura T
    Vaccine; 1997 Oct; 15(15):1598-605. PubMed ID: 9364689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.